- Home
- DOMH vs CLSD Comparison
DOMH vs CLSD Comparison
Compare DOMH & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOMH
- CLSD
- Stock Information
- Founded
- DOMH 1967
- CLSD 2011
- Country
- DOMH United States
- CLSD United States
- Employees
- DOMH N/A
- CLSD N/A
- Industry
- DOMH Biotechnology: Pharmaceutical Preparations
- CLSD Biotechnology: Pharmaceutical Preparations
- Sector
- DOMH Health Care
- CLSD Health Care
- Exchange
- DOMH Nasdaq
- CLSD Nasdaq
- Market Cap
- DOMH 68.4M
- CLSD 68.6M
- IPO Year
- DOMH N/A
- CLSD 2016
- Fundamental
- Price
- DOMH $5.91
- CLSD $0.88
- Analyst Decision
- DOMH
- CLSD Strong Buy
- Analyst Count
- DOMH 0
- CLSD 5
- Target Price
- DOMH N/A
- CLSD $5.00
- AVG Volume (30 Days)
- DOMH 300.4K
- CLSD 121.6K
- Earning Date
- DOMH 05-27-2025
- CLSD 05-14-2025
- Dividend Yield
- DOMH 5.41%
- CLSD N/A
- EPS Growth
- DOMH N/A
- CLSD N/A
- EPS
- DOMH N/A
- CLSD N/A
- Revenue
- DOMH $24,891,000.00
- CLSD $3,764,000.00
- Revenue This Year
- DOMH N/A
- CLSD N/A
- Revenue Next Year
- DOMH N/A
- CLSD $476.77
- P/E Ratio
- DOMH N/A
- CLSD N/A
- Revenue Growth
- DOMH 789.95
- CLSD N/A
- 52 Week Low
- DOMH $0.83
- CLSD $0.70
- 52 Week High
- DOMH $13.58
- CLSD $1.65
- Technical
- Relative Strength Index (RSI)
- DOMH 57.32
- CLSD 52.65
- Support Level
- DOMH $5.36
- CLSD $0.83
- Resistance Level
- DOMH $6.21
- CLSD $0.94
- Average True Range (ATR)
- DOMH 0.54
- CLSD 0.06
- MACD
- DOMH 0.06
- CLSD 0.01
- Stochastic Oscillator
- DOMH 64.36
- CLSD 53.41
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.